Accreditation Statement
In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint Accreditation In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement Physicians
The ACCF designates this online enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field. Nurses The ACCF designates this educational activity for a maximum of 0.25 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
MOC Information
Successful completion of this certified activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Pharmacists ACCF designates this continuing education activity for 0.25 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education.
Target Audience:
This activity is intended for CV team clinicians who are involved in lipid-lowering treatment planning, including physicians, nurse practitioners, physician assistants, and pharmacists.
Important Dates: Date of Release: August 12, 2021 Term of Approval/Date of Expiration: August 12, 2022 Learner Objectives: Upon completion of this activity, you should be able to:
Acknowledgements: Educational grant support provided by: Amgen and Novartis Pharmaceuticals Corporation.
Faculty:
Mahmoud Al Rifai, MD, MPH
Salim Virani, MD, FACC
Peer Reviewers:
Kim Birtcher, PharmD, AACC Keith Ferdinand, MD, FACC